Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
Levels of the huntingtin protein can be directly measured in blood - could this be useful for gene silencing studies?
Watch the full video of EuroBuzz day 1 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm
EuroBuzz news: Day 3. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm
HD patients are less likely to get cancer, according to a study from Sweden - what does this mean?
More reasons to be active: a passive lifestyle may contribute to earlier onset of symptoms in HD.
Smaller total brain volumes in male HD mutation carriers suggests brain development may be different in HD.
Merger of two major Huntington’s Disease observational trials creates ENROLL-HD